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Abstract. 
 
The [URE3] prion (infectious protein) of yeast
is a self-propagating, altered form of Ure2p that cannot
carry out its normal function in nitrogen regulation. Previ-
ous data have shown that Ure2p can form protease-resis-
 
tant amyloid ﬁlaments
 
 
 
in vitro, and that it is aggregated in
cells carrying the [URE3] prion. Here we show by electron
microscopy that [URE3] cells overexpressing Ure2p con-
tain distinctive, ﬁlamentous networks in their cytoplasm,
and demonstrate by immunolabeling that these networks
contain Ure2p. In contrast, overexpressing wild-type cells
show a variety of Ure2p distributions: usually, the protein is
dispersed sparsely throughout the cytoplasm, although oc-
casionally it is found in multiple small, focal aggregates.
However, these distributions do not resemble the single,
large networks seen in [URE3] cells, nor do the control
cells exhibit cytoplasmic ﬁlaments. In [URE3] cell extracts,
Ure2p is present in aggregates that are only partially solu-
bilized by boiling in SDS and urea. In these aggregates, the
 
NH
 
2
 
-terminal prion domain is inaccessible to antibodies,
whereas the COOH-terminal nitrogen regulation domain
is accessible. This ﬁnding is consistent with the proposal
that the prion domains stack to form the ﬁlament back-
bone, which is surrounded by the COOH-terminal do-
mains. These observations support and further specify the
concept of the [URE3] prion as a self-propagating amyloid.
 
Key words: amyloid • yeast prion • immunoelectron
microscopy • protease resistance • Ure2p.
 
Introduction
 
The [URE3] prion (infectious protein) concept arose in
studies of the transmissible spongiform encephalopathies
 
(TSEs)
 
1
 
 of mammals (Alper et al., 1967; Griffith, 1967;
Prusiner, 1982). The remarkable UV radiation resistance
of the scrapie agent (Alper et al., 1967) led to speculation
that the infectious agent might not involve nucleic acids,
and might instead be a sort of nucleation phenomenon
(Griffith, 1967), precisely the present concept of this dis-
 
ease. 
 
Sinc, 
 
a chromosomal gene controlling the disease
(Dickinson et al., 1968) encodes the major protein compo-
nent (PrP) of infectious material (Bolton et al., 1982;
Chesebro et al., 1985; Oesch et al., 1985; Carlson et al.,
1986). Considerable evidence has now accumulated in sup-
port of the idea that scrapie is an infectious form of the
PrP protein, although attempts to induce infectious scrapie
de novo using recombinant PrP protein or transgenes have
not yet succeeded.
 
[URE3] and [PSI
 
 
 
] are nonchromosomal genetic ele-
ments of 
 
Saccharomyces
 
 
 
cerevisiae
 
 (Cox, 1965; Lacroute,
1971). Stringent genetic criteria were formulated to distin-
guish prions from nucleic acid replicons or other epige-
netic phenomena, and it was shown that [URE3] and
[PSI
 
 
 
] satisfy these criteria as prions of Ure2p and
Sup35p, respectively (Wickner, 1994). Ure2p normally
regulates nitrogen catabolism, but on rare occasions can
change to an inactive form that is able to convert the nor-
mal (active) form into the same inactive state. The Sup35
protein is a subunit of the translation termination factor,
and in the same way, a self-propagating, inactive form of
Sup35p was identified as the [PSI] nonchromosomal ge-
netic element (for review see Wickner et al., 2000). Al-
though the agents of TSEs kill infected cells, and [URE3]
or [PSI
 
 
 
] at most only retard growth, these infections are
believed to have similar mechanisms, i.e., self-propagating
amyloids. TSEs are often associated with amyloid deposi-
tion in infected tissues, and both Sup35p and Ure2p have
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Figure 1.
 
Filamentous aggregates in the cytoplasm of [URE3]
cells overexpressing Ure2p. (A) Electron micrograph of a thin
section through a [URE3] cell showing a cytoplasmic aggregate
of 20–30 nm fibrils (arrows). (B and C) Enlarged views of aggre-
gates from A (C) and from another cell (B). N, nucleus; V, vacu-
ole. Bar, 0.5 
 
 
 
m.
 
been shown to form amyloids in vitro (Glover et al., 1997;
King et al., 1997; Taylor et al., 1999).
Both Ure2p and Sup35p have Asn–Gln-rich NH
 
2
 
-ter-
minal “prion domains” (Tuite, 2000). Deletion analysis
showed that the Ure2p prion domain, residues 1–80, is nec-
essary for prion-based inactivation of Ure2p, and sufficient
to induce the de novo appearance of [URE3] when overex-
pressed in a normal cell (Masison and Wickner, 1995, Mad-
delein and Wickner, 1999). Moreover, the peptide cover-
ing residues 1–65 spontaneously forms amyloid filaments
in vitro (Taylor et al., 1999). The COOH-terminal portion,
residues 81–354, is sufficient to carry out the nitrogen regu-
lation function (Coschigano and Magasanik, 1991; Masison
and Wickner, 1995). Full-length native Ure2p is a stable,
soluble dimer, but forms cofilaments when the prion do-
main peptide is added. This in vitro
 
 
 
amyloid formation is
highly specific and selfpropagating, thus providing a possi-
ble explanation for the [URE3] prion (Taylor et al., 1999).
We have sought to clarify this hypothesis by examining
the state of Ure2p in [URE3] cells by electron microsopy.
Intracellular aggregation has been shown by fluorescence
light microscopy of green fluorescent protein (GFP) fusions
with Sup35p (Patino et al., 1996) and Ure2p (Edskes et al.,
1999). In the latter case, Ure2p was aggregated in [URE3]
cells, but evenly distributed through the cytoplasm of nor-
mal cells, and aggregation was induced only in molecules
containing the prion domain. However, intracellular amy-
loid filaments have not been demonstrated for any yeast
prion. Here we report visualization of such filaments in
[URE3] cells in thin sections and immunolabeling studies
with antibodies specific to both the COOH- and NH
 
2
 
-ter-
minal domains of Ure2p. To complement these observa-
tions, we extracted Ure2p from [URE3] cells and found it
to be in large aggregates that resemble in vitro–produced
Ure2p amyloid, insofar as its insolubility in denaturants and
resistance to proteinase K digestion (Masison and Wickner,
1995). Taken together, these observations establish a link
between the in vivo and in vitro data that support the con-
cept of the [URE3] prion as a self-propagating amyloid.
 
Materials and Methods 
 
Antibody Production
 
A Ure2p (64–339)–His
 
6
 
 fusion was constructed by PCR, and expressed in
 
Escherichia coli
 
 K38 using the pT7.7 vector (gift of Dr. Herbert Tabor,
National Institutes of Health). The fusion protein was purified by NiNTA-
agarose chromatography and 12% SDS-PAGE. The Coomassie blue–
stained band was used to generate the rabbit polyclonal antiserum
(Babco), Ure2-3C. The AminoLink Plus Immobilization Kit (Pierce
Chemical Co.) and recombinant His
 
6
 
–Ure2p were used for affinity purifi-
cation of the antibody. The antibody specific for the NH
 
2
 
-terminal domain
has been described (Wickner, 1994; Taylor et al., 1999).
 
Thin Section Electron Microscopy 
 
Cells of the isogenic strains YHE134 (
 
MAT
 
a
 
/
 
MAT
 
α
 
 
 
ura2
 
/
 
ura2 leu2
 
/
 
leu2
trp1
 
/
 
 
 
 
 
 
 
/
 
his
 
 
 
pH14 [URE3]) and YHE129 (
 
MAT
 
a
 
/
 
MAT
 
α
 
 
 
ura2
 
/
 
ura2 leu2
 
/
 
leu2 trp1
 
/
 
 
 
 
 
 
 
/
 
his
 
 
 
 pH14 [ure-o]) were grown in leucine dropout medium
to exponential phase. For ultrastructural analysis, they were processed ac-
cording to Byers and Goetsch (1991), except that 0.1 mg/ml zymolase 20T
(Seikagaku Corp.) was used in addition to 10% vol/vol glusulase (Dupont;
NEN Life Science Products) to remove the cell wall. After fixation with
2% glutaraldehyde on ice overnight, cells were treated with the enzymes
for 2 h at 30
 
 
 
C, postfixed with 2% osmium tetroxide, treated en bloc with
1% uranyl acetate, dehydrated, and embedded in Spurr resin. Silver/gray
sections were stained with 2% uranyl acetate followed by Reynolds lead
citrate. All grids, including those with immunolabeled specimens de-
scribed below, were examined in a ZEISS EM902 at 80 kV using the en-
ergy-filtering system in “zero-loss” mode.
 
Immunogold Labeling 
 
Cryosections were prepared according to van Tuinen (1996). Thawed cry-
osections were blocked on drops of 5% BSA/0.1% cold water fish skin
gelatin in PBS for 30 min, incubated for 40 min on the affinity-purified
COOH-terminal antibody, washed, and transferred for 40 min to a drop of
protein A–gold (10 nm; Sigma-Aldrich) diluted to A
 
520
 
 
 
  
 
0.05. Both the
primary antibody and protein A–gold were diluted in PBS containing
0.1% BSA-c (Aurion). In the absence of the antibody, the protein A–gold
conjugate did not react with the cell sections. After extensive washing
with PBS, sections were fixed with 2% glutaraldehyde for 10 min and con-
trasted with methylcellulose–uranyl acetate (Griffiths et al., 1984).
To quantitate the incidence of aggregates in [URE3] cells, micrographs
of 127 randomly chosen cell sections were recorded at a magnification of
12,000. 54 of these were eliminated as either too small (tangential sections)
or poorly preserved. Of the remaining 73, 4 had aggregates of 3–6 
 
 
 
m in
diameter, 3 had aggregates of 0.8–1.5 
 
 
 
m, 3 had aggregates of 0.4–0.8 
 
 
 
m,
and 6 had short lines of 3–5 closely spaced gold particles. In comparison,
no such alignments were seen in 
 
 
 
300 examples
 
 
 
of the majority kind of
control [ure-o] sections (see Fig. 3 A), whereas the two other kinds of [ure-o]
labeling patterns (see Fig. 3, B and C) were qualitatively different, rare,
and readily recognizable. To assess the average densities of dispersed gold
particles, we measured the areas and counted the gold particles of 20
[URE3] sections (minus areas with aggregates) and 15 [ure-o] sections.
 
Proteinase K Assays 
 
In 320 
 
 
 
l, 45 
 
 
 
g of proteinase K was added to 800 
 
 
 
g of cell extract pro-
tein in 50 mM Tris-HCl (pH 7.5) containing 0.15 M NaCl, and incubated
at 37
 
 
 
C. At 0, 1, 2, 5, 10, 15, and 30 min, 32 
 
 
 
l of the reaction was quenched
by the addition of 34 
 
 
 
l of 8 M urea and 14 
 
 
 
l of SDS-PAGE loading
buffer containing 2 mM PMSF. Samples were boiled for 5 min and 30-
 
 
 
l
aliquots were loaded onto a 10–20% SDS-PAGE. The gels were blotted
on to polyvinylidene difluoride membranes, and immunoblots were
probed with an antibody specific for the NH
 
2
 
-terminal region of Ure2p
(Wickner, 1994; Taylor et al., 1999).
 
Results and Discussion
 
Aggregates of Ure2p-containing Filaments in [URE3] Cells 
 
Yeast cells with the [URE3] prion and control [ure-o] cells
were thin sectioned after fixation and embedding in an ep-
oxy resin. Distinctive filamentous aggregates were seen in
the cytoplasm of [URE3] cells of a strain that overex-
presses Ure2p (Fig. 1). Large aggregates, at least 3 
 
 
 
m
across, were seen in 5–10% of cell profiles, with smaller
aggregates (or peripheral sections of large aggregates) be-
ing observed with a similar frequency (see below). These
structures were never seen in control sections of [ure-o]
cells. In sections showing these structures, there was typi-
cally one such aggregate, which was approximately globu-
lar in outline. They contain irregularly associated fila-
ments 
 
 
 
25 nm in diameter. In sections of [URE3] cells
expressing normal levels of Ure2p, we observed a few can- 
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didate filamentous features but not frequently enough to
allow conclusive identification (data not shown).
Because these aggregates were found only in [URE3]
cells, and filaments of similar diameter have been assem-
bled from Ure2p
 
 
 
in vitro (Taylor et al., 1999; Schlump-
berger et al., 2000), we suspected that they contain Ure2p.
To test this hypothesis, we prepared cryosections and la-
beled them with affinity-purified polyclonal antibodies
raised against the COOH-terminal moiety of Ure2p (resi-
dues 64–339, Materials and Methods). Heavy and very spe-
cific labeling of the aggregates was observed (Fig. 2). The
location and dimensions of the labeled regions matched
those of the networks seen in the epoxy sections, as did
their incidence. 5–10% of sections had a large aggregate
and, when present, there was usually only one aggregate
per cell section. Cryosections being less efficacious for con-
veying substructure, the filamentous substructure was less
apparent in these micrographs, but the aggregates tended
to stain more heavily than the surrounding cytoplasm.
However, many of the gold particles were organized in lin-
ear formations (Fig. 2), attesting to filamentous organiza-
tion of the antigen. Qualitatively similar but weaker and
less specific labeling was observed with an antibody against
the NH
 
2
 
-terminal prion domain (data not shown).
As a control, we performed immunolabeling on [ure-o]
cells overexpressing Ure2p at approximately the same
level, as judged by protein detected with the COOH-ter-
minal antibody. Several labeling patterns were observed.
Most sections (
 
 
 
80%) showed sparse labeling throughout
the cell (Fig. 3 A), occasionally with multiple small, focal
concentrations of gold particles (Fig. 3 C). The remainder
showed less regular (i.e., less round) concentrations of
gold particles (Fig. 3 B), as if Ure2p were associated with
an intracellular membrane, or no labeling, as if the plas-
mid had been lost. All these patterns were quite distinct
from the labeling seen on [URE3] sections. Because dif-
ferent patterns were encountered on adjacent areas of the
same [ure-o] section, their diversity does not reflect varia-
tions in procedure. Rather, we speculate that it may repre-
sent fortuitously different levels of Ure2p expression or
differing stages of the cell cycle. Importantly, filaments
were never observed in epoxy sections of these cells, and
we have no reason to suppose that they harbor any Ure2p-
containing filaments. 
 
Fraction of Cells Containing Filamentous Aggregates
 
As noted above, we reproducibly saw a large aggregate in
5–10% of sections of [URE3] cells overexpressing Ure2p
 
.
 
This is quite a small fraction and raises the question of
how many cells actually contain filaments. The compact
nature of the aggregates implies that a considerably higher
 
percentage of cells harbor such a structure as many ran-
dom sections will miss the aggregate. To estimate this ef-
fect quantitatively, we first included all sections that
showed smaller aggregates or even single filaments. Al-
though we could not identify them in epoxy sections, we
could detect filaments with the immunogold method as
alignments of at least three closely spaced gold particles.
This identification was possible because of the low level
and random nature of background labeling obtained with
this antibody (Materials and Methods). In this analysis, a
total of 22%, i.e., 16 of 73 randomly chosen sections,
scored positive for aggregates or at least one filament.
To put this number in context, we measured the fraction
of cell sections that showed a nucleus and obtained a value
of 29%, although every cell should have one. Comparing this
number with the 22% of sections that show aggregates or fil-
aments, and bearing in mind that the latter structures, being
generally smaller than nuclei, are more likely to be missed,
there is no discrepancy between these data and the proposi-
tion that essentially all of these cells contain filaments, ag-
gregated or otherwise. Moreover, the density of single, ran-
domly dispersed gold particles on [URE3] sections was very
low, essentially at background level, and markedly less than
on [ure-o] sections (0.8 vs. 14 gold particles per
 
 
 
 
 
m
 
2
 
, respec-
tively). This observation suggests that almost all of the
Ure2p in the [URE3] cells was in aggregates
 
.
 
We also attempted to visualize filaments in normally ex-
pressing [URE3] cells by these methods, but did not ob-
tain conclusive results. Because the level of Ure2p expres-
sion was 
 
 
 
20-fold lower, the frequency of observing the
structures of interest was presumably reduced to a prohib-
itively low level. Nevertheless, we suppose that a similar
mechanism is in effect in these cells, i.e., amyloid filaments
are present which sequester and inactivate Ure2p, but
have not accumulated in amounts large enough to be seen
in our sections
 
.
 
Masking of NH
 
2
 
-terminal Epitope in Ure2p-containing 
Aggregates from [URE3] Cells 
 
To complement these in situ observations, we examined
Ure2p aggregates in extracts from prion-infected cells.
Cells were suspended in buffer in 8 M urea and broken
with glass beads. The whole cell extract was analyzed by
SDS-PAGE after boiling in SDS-containing buffer, and
probed by Western blotting with antibody specific for ei-
ther the NH
 
2
 
 terminus or the COOH terminus of Ure2p
(Fig. 4, left). In [URE3] extracts, the COOH-terminal–
specific antibody detected at least 75% of Ure2p-contain-
ing material as aggregates that were retained in the stack-
ing gel (Fig. 4, left, upper arrow). No such material was de-
tected in [ure-o] extracts, in which Ure2p ran as a
monomer. The [URE3] extracts also yielded some mono-
mer, but in very low amounts if the concentration of urea
was reduced (data not shown). These observations indi-
cate that most Ure2p is aggregated in [URE3] cells, and
that the minority of monomers most likely derive from
small aggregates solubilized by the urea–SDS treatment.
Interestingly, the [URE3]-derived aggregates were not de-
tected by the NH
 
2
 
-terminal antibody, which readily de-
tected the monomeric species (Fig. 4, left). We conclude
that its epitope is masked in the aggregates.
 
Figure 2.
 
Cytoplasmic aggregates in [URE3] cells are labeled by
anti-Ure2p antibodies.
 
 
 
Cryosections were incubated with an af-
finity-purified antibody against the COOH-terminal domain of
Ure2p. 10 nm gold particles show highly specific binding of the
antibodies to cytoplasmic aggregates (A and B). Note the almost
complete absence of label elsewhere in the cell. In the aggre-
gates, gold particles are often locally organized in linear strands,
suggesting multiple labeling of filaments. N, nucleus; V, vacuole.
Bar, 0.5 
 
 
 
m. 
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Figure 4. Solubility, antibody reactivity, and protease resistance of Ure2p in extracts of [URE3] and [ure-o] cells. [ure-o] (YHE129) and
[URE3] (YHE134) cells carrying pH14 were suspended in 8 M urea, 100 mM Tris-HCl, pH 8.0, and were broken using a bead beater (2  
3 min). (Left) Extract protein (15  g) was boiled for 5 min in a total of 24  l of SDS-PAGE loading buffer containing a final concentra-
tion of 3 M urea and 2% SDS. Samples were run on a 10–20% SDS-PAGE and immunoblotted with anti-Ure2p antibodies specific to ei-
ther the NH2 or COOH terminus. (Right) Protease resistance of Ure2p in extracts of [URE3] cells (see Materials and Methods).
 
Figure 3
 
. Immunoelectron microscopy of control [ure-o] cells.
Most labeled cryosections (
 
 
 
80%) exhibit a sparse distribution
of gold particles all over the cell (e.g., A). Approximately 5% of
sections show concentrations of label at the cell periphery (B).
Another 5–10% show one or more focal clusters within which the
gold particles appear to be distributed randomly (C), in addition
to diffuse labeling elsewhere. Bar, 0.5 
 
 
 
m.
 
Ure2p in extracts from [URE3] cells also differs from
the protein from [ure-o] cells in terms of resistance to pro-
teinase K digestion. Whereas the latter material rapidly
disappeared over the time course of the experiment, resis-
tant fragments with apparent molecular masses of 
 
 
 
30
and 14 kD accumulated in the [URE3] digestion (Fig. 4,
right). Fragments with these molecular weights were de-
tected previously in digestion of in vitro–assembled amy-
loid filaments (Taylor et al., 1999)
 
.
 
A Molecular Model for Ure2p Amyloid 
 
The above observations support the proposal (Taylor et
al., 1999) whereby the NH
 
2
 
-terminal domains stack axially
to form the filament backbone from which the COOH-ter-
minal domains protrude (Fig. 5). Sequestration of the NH
 
2
 
termini in this way explains their inaccessibility to the
NH
 
2
 
-terminal antibody. It also accounts for the lower re-
activity of the NH
 
2
 
-terminal antibody with cryo-sections,
although as expected, some labeling was observed as
cross-cutting should expose some NH
 
2
 
-terminal epitopes.
A central tenet of the prion scenario is that Ure2p is in-
activated in the polymerized form. Because the COOH-
 
terminal domains carry its regulatory activity and are ex-
ternally exposed, they are potentially accessible to reac-
tion partners. Accordingly, their inactivation may be ac-
complished by at least partial unfolding upon becoming
incorporated into the filament, or by steric inhibition of
their functional sites (but not the whole domain), as
packed in filaments. The former explanation is favored by
the observed enhancement of 
 
 
 
-sheet content when Ure2p
enters its filamentous state (Taylor et al., 1999; Schlump-
berger et al., 2000).
 
Curing and Induction of [URE3] as 
Expression-dependent Phenomena 
 
Although
 
 
 
genetic and biochemical evidence for yeast pri-
ons is now strong (reviewed by Wickner et al., 2000), the
mechanism of prion propagation is not as well understood.
Both Ure2p and Sup35p have Asn–Gln-rich NH
 
2
 
-terminal
domains that are essential for prion generation and propa-
gation (TerAvanesyan et al., 1994; Masison and Wickner,
1995, Maddelein and Wickner, 1999; DePace et al., 1998).
Aggregation of Ure2p and Sup35p is an important feature
of [URE3] and [PSI
 
 
 
], respectively (Patino et al., 1996;
Paushkin et al., 1996; Edskes et al., 1999), but the nature of
this aggregation has not been clear. GFP fusions with
Ure2p form globular aggregates in [URE3] cells (Edskes
et al., 1999). At first sight, the nonfilamentous nature of
these aggregates might be considered as counter to the
amyloid filament hypothesis (although some “filiform” ag-
gregates have been reported in cells expressing the fusion
of a mutant Ure2p with GFP [Fernandez-Bellot et al.,
2000]). The present results account for this observation in
that they reveal that the globular aggregates in [URE3] 
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cells are tangles of filaments that are not resolved as such
at the resolution of light microscopy.
Key to the concept of the [URE3] prion as a self-propa-
gating amyloid is the provision that when cells divide, each
daughter cell should receive at least one amyloid particle
(a filament or aggregate of filaments) that then recruits
newly expressed Ure2p and so maintains the [URE3] phe-
notype. In this context, it appears paradoxical that overex-
pression of the Ure2p prion domain should induce [URE3]
in an initially [ure-o] cell, but the same overexpression of
the same prion domain fragment in an initially [URE3] cell
should cure it. The former phenomenon is readily ex-
plained by the observed efficacy of the prion domain in in-
ducing cofilament assembly
 
 
 
in vitro. The latter phenome-
non has been discussed in terms of a poisoning of the prion
“crystal” growth by incorporation of heterologous compo-
nents (Edskes et al., 1999). Peptides of PrP inhibiting the
propagation of scrapie in tissue culture cells have been
similarly interpreted (Chabry et al., 1999). The observation
that the amyloid filaments coalesce into single large aggre-
gates in overexpressing [URE3] cells suggests an alterna-
tive curing mechanism. A larger aggregate may be more
likely to soak up all the amyloid filaments, so that one of
the daughter cells receives that aggregate and the other re-
ceives no amyloid and hence is cured. We observed more
than one network within the same cell section only rarely,
but cannot say that following or preceding sections of the
same cell would not reveal another network (and Ure2p–
GFP fusion proteins often show more than one aggregate
per cell [Edskes et al., 1999]). However, it is clear that the
number of aggregates per cell is small, and with two or
three aggregates the chances of cosegregation would still
be high enough to support this curing mechanism.
 
Both [PSI
 
 
 
] and [URE3] require the chaperone Hsp104
for their stable propagation (Chernoff et al., 1995; Mori-
yama et al., 2000). It was suggested that Hsp104 may help
in the conversion of normal Sup35p and Ure2p to their al-
tered forms (Chernoff et al., 1995). However, the disag-
gregating ability of Hsp104 (Parsell et al., 1994) and the
finding that Sup35p is aggregated in [PSI
 
 
 
] extracts led
Paushkin et al. (1996) to suggest that Hsp104’s role may be
to split up Sup35p aggregates to ensure equal distribution
of the prion form to daughter cells in cell division. This
segregational role of Hsp104 is also possible in [URE3],
and is suggested by our finding that we mainly observe
Ure2p in overexpressing [URE3] cells to be present in sin-
gle large aggregates rather than dispersed populations of
filaments. Without a disaggregating function, it is likely
that one daughter cell would receive no filaments and thus
be cured.
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